Page
%P
-
Article
Open AccessPhase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks
To determine the maximum-tolerated dose (MTD), dose-limiting toxicities, and pharmacokinetics of topotecan administered as a 30-min intravenous (i.v.) infusion over 5 days in combination with a 1-h i.v. infusi...